ClearideBio Therapeutics
ClearideBio Therapeutics is an early-stage, swiss-based biopharmaceutical startup developing next-generation cancer therapies.
Pre Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredOct 2, 2025 (14 months old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Pre Seed | undisclosed | — | — |
Timeline
- Website created
Founders and team
XJ
Xiaona Jing CEO & Co-Foundersource: clearidebiotx.comPC
Pawel Chrom CMO & Co-Foundersource: clearidebiotx.com
Companies like ClearideBio Therapeutics
SSleptaySeries A · Sep 2026
DDren Bio$350M Series B+ · Oct 2026AATB Therapeutics$57M Series A · Dec 2024
DDomain Therapeutics$41M Series A · May 2022
AAdcytherixSeries A · Oct 2025
KKaliVir Immunotherapeutics$14M Series A · Aug 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/clearidebio-therapeutics (get a free API key).